# EDGAR Filing Document

**Accession Number:** 0002043390
**File Stem:** 0002000324-26-001172
**Filing Date:** 2026-3
**Character Count:** 26053
**Document Hash:** caaa2ab9c419307fc6bbcb80948a1079
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0002000324-26-001172.hdr.sgml**: 20260326

**ACCESSION NUMBER**: 0002000324-26-001172

**CONFORMED SUBMISSION TYPE**: NPORT-P

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20260131

**FILED AS OF DATE**: 20260326

**DATE AS OF CHANGE**: 20260326

**PERIOD START**: 20261031

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Tidal Trust IV
- **CENTRAL INDEX KEY:** 0002043390

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** NPORT-P
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-24061
- **FILM NUMBER:** 26797656

**BUSINESS ADDRESS:**
- **STREET 1:** 234 WEST FLORIDA STREET, SUITE 700
- **CITY:** MILWAUKEE
- **STATE:** WI
- **BUSINESS PHONE:** 855-832-2534

**MAIL ADDRESS:**
- **STREET 1:** 234 WEST FLORIDA STREET, SUITE 700
- **CITY:** MILWAUKEE
- **STATE:** WI

## Series and Classes Contracts Data

### Portfolio Building Block World Pharma and Biotech Index ETF (Series ID: S000096308)

| Class ID   | Class Name                                                  | Ticker Symbol   |
|:---|:---|:---|
| C000265138 | Portfolio Building Block World Pharma and Biotech Index ETF |  |

## Nport-Ex

---

| | | |
|:---|:---|:---|
| **Portfolio Building Block World Pharma and Biotech Index ETF** | **Portfolio Building Block World Pharma and Biotech Index ETF** | **Portfolio Building Block World Pharma and Biotech Index ETF** |
| **Schedule of Investments** | **Schedule of Investments** | **Schedule of Investments** |
| **January 31, 2026 (Unaudited)** | **January 31, 2026 (Unaudited)** | **January 31, 2026 (Unaudited)** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**COMMON STOCKS - 99.5%** | **Shares** | **Value** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Consumer Staple Products - 1.0%** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Haleon PLC | 72864 | $378853 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Health Care - 98.5%<sup>(a)</sup>** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;AbbVie, Inc. | 10501 | 2341828 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Alnylam Pharmaceuticals, Inc.<sup>(b)</sup> | 1091 | 368823 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amgen, Inc. | 4536 | 1550768 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Argenx SE<sup>(b)</sup> | 541 | 452968 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Astellas Pharma, Inc. | 13832 | 192246 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;AstraZeneca PLC | 8832 | 1648281 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Bayer AG | 8142 | 431616 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Biogen, Inc.<sup>(b)</sup> | 1241 | 223243 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;BioMarin Pharmaceutical, Inc.<sup>(b)</sup> | 1518 | 85828 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Bridgebio Pharma, Inc.<sup>(b)</sup> | 1379 | 106555 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Bristol-Myers Squibb Co. | 16976 | 934529 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Chugai Pharmaceutical Co. Ltd. | 4277 | 244016 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;CSL Ltd. | 4004 | 508883 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Daiichi Sankyo Co. Ltd. | 13800 | 253707 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Elanco Animal Health, Inc.<sup>(b)</sup> | 4139 | 99667 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Eli Lilly & Co. | 5094 | 5283242 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Exact Sciences Corp.<sup>(b)</sup> | 1518 | 155352 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Exelixis, Inc.<sup>(b)</sup> | 2072 | 85698 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Galderma Group AG | 1104 | 206306 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Genmab A/S<sup>(b)</sup> | 535 | 172333 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Gilead Sciences, Inc. | 10351 | 1469324 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;GSK PLC | 32982 | 849296 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Incyte Corp.<sup>(b)</sup> | 1656 | 165716 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Insmed, Inc.<sup>(b)</sup> | 1794 | 281425 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Ionis Pharmaceuticals, Inc.<sup>(b)</sup> | 1379 | 114002 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Johnson & Johnson | 14354 | 3261946 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Madrigal Pharmaceuticals, Inc.<sup>(b)</sup> | 148 | 72418 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Merck & Co., Inc. | 15319 | 1689226 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Merck KGaA | 1103 | 164745 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Natera, Inc.<sup>(b)</sup> | 1104 | 255179 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Neurocrine Biosciences, Inc.<sup>(b)</sup> | 827 | 112522 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Novartis AG | 12007 | 1787212 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Novo Nordisk A/S - Class B | 26635 | 1568050 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Otsuka Holdings Co, Ltd. | 2887 | 172947 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pfizer, Inc. | 47196 | 1247862 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Regeneron Pharmaceuticals, Inc. | 833 | 617628 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Revolution Medicines, Inc.<sup>(b)</sup> | 1380 | 133791 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Roche Holding AG - Class BR | 148 | 68421 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Roche Holding AG, Genusschein Shares | 4154 | 1891835 |

---

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Royalty Pharma PLC - Class A | 2898 | $120789 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Sandoz Group AG | 3450 | 274100 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Sanofi SA | 9522 | 897169 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Shionogi & Co., Ltd. | 4422 | 90986 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Takeda Pharmaceutical Co. Ltd. | 13580 | 461470 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Teva Pharmaceutical Industries Ltd.<sup>(b)</sup> | 9391 | 306915 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;UCB SA | 975 | 296242 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;United Therapeutics Corp.<sup>(b)</sup> | 395 | 185449 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Vertex Pharmaceuticals, Inc.<sup>(b)</sup> | 2082 | 978332 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Viatris, Inc. | 9522 | 124643 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Zoetis, Inc. - Class A | 3726 | 465079 |
|  |  | 35470608 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**TOTAL COMMON STOCKS (Cost $35,721,321)** |  | 35849461 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**SHORT-TERM INVESTMENTS - 0.4%** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Money Market Funds - 0.4%** | **Shares** | **Value** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dreyfus Treasury Securities Cash Management, 3.57%<sup>(c)</sup> | 149553 | 149553 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**TOTAL SHORT-TERM INVESTMENTS (Cost $149,553)** |  | 149553 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**TOTAL INVESTMENTS - 99.9% (Cost $35,870,874)** |  | $35999014 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other Assets in Excess of Liabilities - 0.1% |  | 27299 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**TOTAL NET ASSETS - 100.0%** |  | $36026313 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Percentages are stated as a percent of net assets. |  |  |

---

PLC Public Limited Company

&nbsp;&nbsp;&nbsp;&nbsp;(a) To the extent that the Fund invests more heavily in a particular industry or sector of the economy, its performance will be especially sensitive to developments that significantly affect those industries or sectors.

(b) Non-income producing security.

(c) The rate shown represents the 7-day annualized effective yield as of January 31, 2026.

## Form NPORT-P: Monthly Portfolio Investments Report

### NPORT-P: Part A: General Information

**Item A.1. Information about the Registrant.**

- **a. Name of Registrant:** Tidal Trust IV

- **b. Investment Company Act file number:** 811-24061

- **c. CIK number of Registrant:** 0002043390

- **d. LEI of Registrant:** 2549002AJTPTPGECMC44

- **e. Address and telephone number of Registrant.**

  - **Street Address 1:** 234 West Florida Street

  - **City:** Milwaukee

  - **State:** WI

  - **Foreign country:** US

  - **Zip / Postal Code:** 53204

  - **Telephone number:** 8558432434

**Item A.2. Information about the Series.**

- **a. Name of Series:** Portfolio Building Block World Pharma and Biotech Index ETF

- **b. EDGAR series identifier (if any):** S000096308

- **c. LEI of Series:** 254900RX8NWPLNMG9Q58

**Item A.3. Reporting period.**

- **a. Date of fiscal year-end:** 2026-10-31

- **b. Date as of which information is reported:** 2026-01-31

**Item A.4. Final filing**

Does the Fund anticipate that this will be its final filing on Form N-PORT? **No**

### Fund Information

**Total Assets:** $36081875.83

**Total Liabilities:** $55773.21

**Net Assets:** $36026102.62

**Monthly Return Information**

| Class               | Month 1 Return (%)   | Month 2 Return (%)   | Month 3 Return (%)   |
|:---|:---|:---|:---|
| Class ID C000265138 | 0.32%                | 0.38%                | 3.53%                |

**Monthly Gains & Losses**

| Period   | Net Realized Gain/Loss   | Net Unrealized Appreciation/Depreciation   |
|:---|:---|:---|
| Month 1  | $-0.01                   | $16415.43                                  |
| Month 2  | $437.74                  | $5369.21                                   |
| Month 3  | $-2739.61                | $376218.35                                 |

### Schedule of Portfolio Investments

| Name                         | Title                     | Identifiers                                   | Payoff Profile   | Asset Category   | Issuer Category   | Country   |   Balance | Units   | Value (USD)   | % of Net Assets   | Maturity Date   | Coupon Type   | Annualized Rate (%)   | Restricted?   |   Fair Value Level | Lending Status   |
|:---|:---|:---|:---|:---|:---|:---|---:|:---|:---|:---|:---|:---|:---|:---|---:|:---|
| DREYFUS TRSRY SECURITIES     | DREYFUS TRSRY SECURITIES  | CUSIP: N/A<br>LEI: 549300U78VESCW509025       | Long             | STIV             | RF                | US        |    203751 | NS      | $203751.18    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| MADRIGAL PHARMACEUTICALS     | MADRIGAL PHARMACEUTICALS  | CUSIP: 558868105<br>LEI: 549300CHIMT2EUSNJB60 | Long             | EC               | CORP              | US        |       148 | NS      | $72417.88     | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| UNITED THERAPEUTICS CORP     | UNITED THERAPEUTICS CORP  | CUSIP: 91307C102<br>LEI: 5299005C4HZL4UWROC14 | Long             | EC               | CORP              | US        |       395 | NS      | $185448.55    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| NEUROCINE BIOSCIENCES        | NEUROCRINE BIOSCIENCES IN | CUSIP: 64125C109<br>LEI: 549300FECER0XBN49756 | Long             | EC               | CORP              | US        |       827 | NS      | $112521.62    | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| REGENERON PHARMACEUTICALS    | REGENERON PHARMACEUTICALS | CUSIP: 75886F107<br>LEI: 549300RCBFWIRX3HYQ56 | Long             | EC               | CORP              | US        |       833 | NS      | $617627.85    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| ALNYLAM PHARMACY             | ALNYLAM PHARMACEUTICALS I | CUSIP: 02043Q107<br>LEI: 529900S3ZI14OWRJII50 | Long             | EC               | CORP              | US        |      1091 | NS      | $368823.46    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| NATERA INC                   | NATERA INC                | CUSIP: 632307104<br>LEI: 529900CQ3OZ0A0VYVU59 | Long             | EC               | CORP              | US        |      1104 | NS      | $255178.56    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| BIOGEN INC                   | BIOGEN INC                | CUSIP: 09062X103<br>LEI: W8J5WZB5IY3K0NDQT671 | Long             | EC               | CORP              | US        |      1241 | NS      | $223243.49    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| BRIDGEBIO PHARMA INC         | BRIDGEBIO PHARMA INC      | CUSIP: 10806X102<br>LEI: 54930028YG89VTY2J114 | Long             | EC               | CORP              | US        |      1379 | NS      | $106555.33    | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| IONIS PHARMACEUTICALS INC    | IONIS PHARMACEUTICALS INC | CUSIP: 462222100<br>LEI: 549300SI4ZGLG0BLUZ92 | Long             | EC               | CORP              | US        |      1379 | NS      | $114001.93    | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| REVOLUTION MEDICINES INC     | REVOLUTION MEDICINES INC  | CUSIP: 76155X100<br>LEI: 549300JU3X0LBCQ65892 | Long             | EC               | CORP              | US        |      1380 | NS      | $133791.00    | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| BIOMARIN PHARMACEUTICAL INC  | BIOMARIN PHARMACEUTICAL I | CUSIP: 09061G101<br>LEI: NSLL8ITTRR0J5HEMR848 | Long             | EC               | CORP              | US        |      1518 | NS      | $85827.72     | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| EXACT SCIENCES CORP          | EXACT SCIENCES CORP       | CUSIP: 30063P105<br>LEI: 549300VM3X1FYD4N9Z14 | Long             | EC               | CORP              | US        |      1518 | NS      | $155352.12    | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| INCYTE CORP                  | INCYTE CORP               | CUSIP: 45337C102<br>LEI: 549300Z4WN6JVZ3T4680 | Long             | EC               | CORP              | US        |      1656 | NS      | $165715.92    | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| INSMED INC                   | INSMED INC                | CUSIP: 457669307<br>LEI: 529900Q55QAG41CCAC11 | Long             | EC               | CORP              | US        |      1794 | NS      | $281424.78    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| EXELIXIS, INC.               | EXELIXIS INC              | CUSIP: 30161Q104<br>LEI: 254900PJQB59O2O95R37 | Long             | EC               | CORP              | US        |      2072 | NS      | $85697.92     | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| VERTEX PHARMACEUTICALS       | VERTEX PHARMACEUTICALS IN | CUSIP: 92532F100<br>LEI: 54930015RAQRRZ5ZGJ91 | Long             | EC               | CORP              | US        |      2082 | NS      | $978331.80    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| ZOETIS INC                   | ZOETIS INC                | CUSIP: 98978V103<br>LEI: 549300HD9Q1LOC9KLJ48 | Long             | EC               | CORP              | US        |      3726 | NS      | $465079.32    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| ELANCO ANIMAL HEALTH INC     | ELANCO ANIMAL HEALTH INC  | CUSIP: 28414H103<br>LEI: 549300SHPNDCE059M934 | Long             | EC               | CORP              | US        |      4139 | NS      | $99667.12     | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| AMGEN INC                    | AMGEN INC                 | CUSIP: 031162100<br>LEI: 62QBXGPJ34PQ72Z12S66 | Long             | EC               | CORP              | US        |      4536 | NS      | $1550767.68   | 0.04%             |  |  |  | No            |                  1 | On Loan: No      |
| ELI LILLY & CO               | ELI LILLY & CO            | CUSIP: 532457108<br>LEI: FRDRIPF3EKNDJ2CQJL29 | Long             | EC               | CORP              | US        |      5094 | NS      | $5283242.10   | 0.15%             |  |  |  | No            |                  1 | On Loan: No      |
| VIATRIS INC                  | VIATRIS INC               | CUSIP: 92556V106<br>LEI: 254900ZZTSW7NL773X71 | Long             | EC               | CORP              | US        |      9522 | NS      | $124642.98    | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| GILEAD SCIENCES INC          | GILEAD SCIENCES INC       | CUSIP: 375558103<br>LEI: 549300WTZWR07K8MNV44 | Long             | EC               | CORP              | US        |     10351 | NS      | $1469324.45   | 0.04%             |  |  |  | No            |                  1 | On Loan: No      |
| ABBVIE INC                   | ABBVIE INC                | CUSIP: 00287Y109<br>LEI: FR5LCKFTG8054YNNRU85 | Long             | EC               | CORP              | US        |     10501 | NS      | $2341828.01   | 0.07%             |  |  |  | No            |                  1 | On Loan: No      |
| JOHNSON & JOHNSON            | JOHNSON & JOHNSON         | CUSIP: 478160104<br>LEI: 549300G0CFPGEF6X2043 | Long             | EC               | CORP              | US        |     14354 | NS      | $3261946.50   | 0.09%             |  |  |  | No            |                  1 | On Loan: No      |
| MERCK & CO. INC.             | MERCK & CO. INC.          | CUSIP: 58933Y105<br>LEI: 4YV9Y5M8S0BRK1RP0397 | Long             | EC               | CORP              | US        |     15319 | NS      | $1689226.13   | 0.05%             |  |  |  | No            |                  1 | On Loan: No      |
| BRISTOL-MYERS SQUIBB CO      | BRISTOL-MYERS SQUIBB CO   | CUSIP: 110122108<br>LEI: HLYYNH7UQUORYSJQCN42 | Long             | EC               | CORP              | US        |     16976 | NS      | $934528.80    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| PFIZER INC                   | PFIZER INC                | CUSIP: 717081103<br>LEI: 765LHXWGK1KXCLTFYQ30 | Long             | EC               | CORP              | US        |     47196 | NS      | $1247862.24   | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| ROCHE HOLDING AG-BR          | ROCHE HOLDING AG-BR       | CUSIP: N/A<br>LEI: 549300U41AUUVOAAOB37       | Long             | EC               | CORP              | US        |       148 | NS      | $68421.53     | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| GENMAB A/S                   | GENMAB A/S                | CUSIP: N/A<br>LEI: 529900MTJPDPE4MHJ122       | Long             | EC               | CORP              | DK        |       535 | NS      | $172333.21    | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| ARGENX SE                    | ARGENX SE                 | CUSIP: N/A<br>LEI: 7245009C5FZE6G9ODQ71       | Long             | EC               | CORP              | NL        |       541 | NS      | $452967.95    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| UCB SA                       | UCB SA                    | CUSIP: N/A<br>LEI: 2138008J191VLSGY5A09       | Long             | EC               | CORP              | BE        |       975 | NS      | $296241.88    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| MERCK KGAA                   | MERCK KGAA                | CUSIP: N/A<br>LEI: 529900OAREIS0MOPTW25       | Long             | EC               | CORP              | DE        |      1103 | NS      | $164745.35    | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| GALDERMA GROUP AG            | GALDERMA GROUP AG         | CUSIP: N/A<br>LEI: 89450001OK6O8ELQ4584       | Long             | EC               | CORP              | CH        |      1104 | NS      | $206305.56    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| OTSUKA HOLDINGS CO LTD       | OTSUKA HOLDINGS CO LTD    | CUSIP: N/A<br>LEI: 35380026J47X9J295415       | Long             | EC               | CORP              | JP        |      2887 | NS      | $172946.76    | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| ROYALTY PHARMA PLC- CL A     | ROYALTY PHARMA PLC- CL A  | CUSIP: N/A<br>LEI: 549300FGFN7VOK8BZR03       | Long             | EC               | CORP              | US        |      2898 | NS      | $120788.64    | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| SANDOZ GROUP AG              | SANDOZ GROUP AG           | CUSIP: N/A<br>LEI: 5493000JWK6XWFEUD320       | Long             | EC               | CORP              | CH        |      3450 | NS      | $274100.38    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| CSL LTD                      | CSL LTD                   | CUSIP: N/A<br>LEI: 529900ECSECK5ZDQTE14       | Long             | EC               | CORP              | AU        |      4004 | NS      | $508883.45    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| ROCHE HOLDING AG-GENUSSCHEIN | ROCHE HOLDING AG-GENUSSCH | CUSIP: N/A<br>LEI: 549300U41AUUVOAAOB37       | Long             | EC               | CORP              | US        |      4154 | NS      | $1891835.34   | 0.05%             |  |  |  | No            |                  1 | On Loan: No      |
| CHUGAI PHARMACEUTICAL CO LTD | CHUGAI PHARMACEUTICAL CO  | CUSIP: N/A<br>LEI: 529900T9LAII161DCN95       | Long             | EC               | CORP              | JP        |      4277 | NS      | $244015.80    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| SHIONOGI & CO LTD            | SHIONOGI & CO LTD         | CUSIP: N/A<br>LEI: 35380049VXDTHZI3DY35       | Long             | EC               | CORP              | JP        |      4422 | NS      | $90985.53     | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| BAYER AG-REG                 | BAYER AG-REG              | CUSIP: N/A<br>LEI: 549300J4U55H3WP1XT59       | Long             | EC               | CORP              | DE        |      8142 | NS      | $431615.69    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| ASTRAZENECA PLC              | ASTRAZENECA PLC           | CUSIP: N/A<br>LEI: PY6ZZQWO2IZFZC3IOL08       | Long             | EC               | CORP              | GB        |      8832 | NS      | $1648281.26   | 0.05%             |  |  |  | No            |                  1 | On Loan: No      |
| TEVA PHARMACEUTICAL IND LTD  | TEVA PHARMACEUTICAL IND L | CUSIP: N/A<br>LEI: 549300BAFGM4RC74ZJ94       | Long             | EC               | CORP              | IL        |      9391 | NS      | $306915.29    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| SANOFI                       | SANOFI                    | CUSIP: N/A<br>LEI: 549300E9PC51EN656011       | Long             | EC               | CORP              | US        |      9522 | NS      | $897169.10    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| NOVARTIS AG-REG              | NOVARTIS AG-REG           | CUSIP: N/A<br>LEI: 5493007HIVTX6SY6XD66       | Long             | EC               | CORP              | US        |     12007 | NS      | $1787211.66   | 0.05%             |  |  |  | No            |                  1 | On Loan: No      |
| TAKEDA PHARMACEUTICAL CO LTD | TAKEDA PHARMACEUTICAL CO  | CUSIP: N/A<br>LEI: 549300ZLMVP4X0OGR454       | Long             | EC               | CORP              | JP        |     13580 | NS      | $461469.99    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| DAIICHI SANKYO CO LTD        | DAIICHI SANKYO CO LTD     | CUSIP: N/A<br>LEI: 353800XGIU2IHQGC9504       | Long             | EC               | CORP              | JP        |     13800 | NS      | $253706.73    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| ASTELLAS PHARMA INC          | ASTELLAS PHARMA INC       | CUSIP: N/A<br>LEI: 529900IB708DY2HBBB35       | Long             | EC               | CORP              | JP        |     13832 | NS      | $192245.61    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| NOVO NORDISK A/S-B           | NOVO NORDISK A/S-B        | CUSIP: N/A<br>LEI: 549300DAQ1CVT6CXN342       | Long             | EC               | CORP              | DK        |     26635 | NS      | $1568050.13   | 0.04%             |  |  |  | No            |                  1 | On Loan: No      |
| GSK PLC                      | GSK PLC                   | CUSIP: N/A<br>LEI: 5493000HZTVUYLO1D793       | Long             | EC               | CORP              | US        |     32982 | NS      | $849295.67    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| HALEON PLC                   | HALEON PLC                | CUSIP: N/A<br>LEI: 549300PSB3WWEODCUP19       | Long             | EC               | CORP              | US        |     72864 | NS      | $378853.21    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |

### Signature

**Date Signed:** 2026-03-26

**Name of Applicant:** Tidal Trust IV

**Signature:** /s/ Aaron Perkovich

**Name of Signer:** Aaron Perkovich

**Title:** Treasurer/Principal Financial Officer